Patents by Inventor Jürgen Eck

Jürgen Eck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180016543
    Abstract: A method of producing yeast mutants and the use thereof. In order to provide yeasts which, at a given sugar content, produce a low ethanol content and a relatively high glycerol content in ethanolic fermentation and which are simultaneously obtainable rapidly, at least one yeast strain is contacted in a first mutagenesis step with a first mutagen and in a second mutagenesis step with a second mutagen. The first and second mutagens are different from one another and are selected from the following groups: nucleotide-alkylating agent, nucleotide-deaminating agent, and UV radiation. The method further includes a first selection step executed between the first and second mutagenesis steps and a second selection step being executed after the second mutagenesis step, in which the mutants that originate from the prior mutagenesis step in each case are exposed to a selection factor selected from the following groups: (a) hypertonic medium and (b) alcohol dehydrogenase inhibitor.
    Type: Application
    Filed: February 4, 2016
    Publication date: January 18, 2018
    Applicants: Erbslöh Geisenheim AG, BRAIN AG
    Inventors: Jürgen FRÖHLICH, Jürgen ECK, Guido MEURER, Christian NAUMER, Jörg BÜSCHER, Jörg MAMPEL
  • Patent number: 9353386
    Abstract: The present invention relates to a host cell having an elevated expression or activity of an enzyme as compared with the parent cell from which it has been derived, said enzyme having lactoyl-CoA reductase activity. Furthermore, provided is a method of producing lactaldehyde and/or 1,2-propanediol, said method comprising culturing said host cell and/or utilizing said enzyme to produce said compound.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: May 31, 2016
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Daniel Koch, Guido Meurer, Jürgen Eck
  • Patent number: 9193961
    Abstract: The present invention relates to a polynucleotide encoding an enzyme having carboxylesterase [E.C.3.1.1.1] activity.
    Type: Grant
    Filed: May 3, 2007
    Date of Patent: November 24, 2015
    Assignee: B.R.A.I.N. AG
    Inventors: Klaus Liebeton, Jürgen Eck, Uwe Bornscheuer, Dominique Böttcher, Peter Langer, Esen Bellur
  • Patent number: 8993743
    Abstract: The present invention relates to a nucleic acid molecule encoding a chimeric protein having the biochemical activity of a surface active protein, wherein said chimeric protein comprises: (a) an N-terminal portion of a first surface active protein, wherein the N-terminal portion is devoid of between 0 and 10 of the most N-terminal amino acids of the mature first surface active protein; and, C-terminally thereof, (b) a C-terminal portion of a second surface active protein, wherein the C-terminal portion is devoid of between 0 and 10 of the most C-terminal amino acids of the mature second surface active protein. The present invention further relates to a vector, a non-human host and a method for the production of a chimeric protein having the biochemical activity of a surface active protein. In addition, the present invention relates to a chimeric protein encoded by the nucleic acid molecule of the invention and a composition comprising the chimeric protein.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: March 31, 2015
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Guido Meurer, Esther Gabor, Anke Bachert, Jürgen Eck
  • Patent number: 8790900
    Abstract: The invention relates to the biotechnological production of isomaltulose and isomaltulose-containing compositions and improved means, therefore particularly microbial cells.
    Type: Grant
    Filed: October 23, 2010
    Date of Patent: July 29, 2014
    Assignee: Südzucker Aktiengesellschaft Mannheim/Ochsenfurt
    Inventors: Stefan Pelzer, Christian Zurek, Thomas Rose, Jürgen Eck, Wolfgang Wach, Michael Klingeberg, Karsten Harms
  • Publication number: 20140178953
    Abstract: The present invention relates to a host cell having an elevated expression or activity of an enzyme as compared with the parent cell from which it has been derived, said enzyme having lactoyl-CoA reductase activity. Furthermore, provided is a method of producing lactaldehyde and/or 1,2-propanediol, said method comprising culturing said host cell and/or utilizing said enzyme to produce said compound.
    Type: Application
    Filed: June 15, 2012
    Publication date: June 26, 2014
    Applicant: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG
    Inventors: Daniel Koch, Guido Meurer, Jürgen Eck
  • Patent number: 8679829
    Abstract: The present invention relates to a sulfolobus expression vector comprising: (a) sulfolobus origin of replication; (b) the genes encoding the structural proteins and the site-specific integrase of SSV1, SSV2 or pSSVx, operatively linked to expression control sequences and a packaging signal; (c) one or more selectable marker gene(s), operatively linked to sulfolobus expression control sequences; and (d) a sulfolobus promoter followed 3? by a restriction enzyme recognition site or a multiple cloning site for insertion of a gene of interest and optionally a 3? regulatory element. Moreover, the present invention relates to a shuttle vector comprising the sequences of the expression vector of the invention and additional sequences for propagation and selection in E. coli, wherein the additional sequences comprise (a) an E. coli on of replication; and (b) a marker for selection in E. coli.
    Type: Grant
    Filed: June 2, 2004
    Date of Patent: March 25, 2014
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Christa Schleper, Melanie Jonuscheit, Jürgen Eck, Frank Niehaus, Sonja-Verena Albers, Sabrina Froels
  • Patent number: 8623810
    Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: January 7, 2014
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn
  • Patent number: 8470576
    Abstract: The present invention provides a polynucleotide or a pair of polynucleotides encoding an enzyme having nitrile hydratase (NHase) [E.C. 4.2.1.84] activity. Furthermore, a vector and a host comprising the disclosed polynucleotide or pair of polynucleotides and methods for the production of the same are provided. Moreover, the invention relates to a pair of polypeptides or a fusion protein having NHase activity, an antibody specifically binding to the pair of polypeptides or fusion protein, a primer or probe, which specifically hybridizes under stringent conditions to the disclosed polynucleotide or either one of the pair of polynucleotides, a composition comprising the polynucleotide or pair of polynucleotides, the pair of polypeptides or fusion protein, the antibody and/or one or more primers or probes of the invention and a method for the production of amides comprising the enantioselective conversion of nitriles.
    Type: Grant
    Filed: April 5, 2007
    Date of Patent: June 25, 2013
    Assignee: B.R.A.I.N. AG
    Inventors: Jürgen Eck, Klaus Liebeton, Lutz Fischer, Sabine Lutz-Wahl, Martina Hensel, Christian Ewert, Marcus Wälz
  • Patent number: 8455107
    Abstract: By treatment with hydrophobins, cellulosic materials such as paper, cardboard, cotton or, especially, wood-based materials, such as solid wood, glued wood products or particle board, can be effectively protected against absorption of and attack by water and/or moisture.
    Type: Grant
    Filed: February 27, 2008
    Date of Patent: June 4, 2013
    Assignee: BASF SE
    Inventors: Esther Gabor, Andreas Buthe, Jürgen Eck, Franz Kaufmann, Hans-Jörg Koch, Guido Meurer
  • Publication number: 20120225458
    Abstract: The invention relates to the biotechnological production of isomaltulose and isomaltulose-containing compositions and improved means, therefore particularly microbial cells.
    Type: Application
    Filed: October 23, 2010
    Publication date: September 6, 2012
    Applicant: SUDZUCKER AKTIENGESELLSCHAFT MANNHEIM/OCHSENFURT
    Inventors: Stefan Pelzer, Christian Zurek, Thomas Rose, Jürgen Eck, Wolfgang Wach, Michael Klingeberg, Karsten Harms
  • Publication number: 20120213764
    Abstract: The present invention relates to a method of producing a peptide consisting of the amino acids 63 to 110 of dermcidin (SEQ ID NO: 3) comprising (a) culturing a host cell carrying a nucleic acid molecule encoding the peptide in an expressible form, and (b) optionally isolating the peptide from the culture. Furthermore, the invention relates to a nucleic acid molecule encoding a fusion protein comprising or consisting of (a) a peptide heterologous with regard to dermcidin protein-tag; and, C-terminally thereof (b) a peptide having the antimicrobial activity of dermcidin wherein the fusion protein contains an arginine residue located immediately N-terminally of the peptide of (b).
    Type: Application
    Filed: September 22, 2010
    Publication date: August 23, 2012
    Applicant: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG
    Inventors: Christian Naumer, Michael Krohn, Yvonne Tiffert, Jürgen Eck
  • Patent number: 8226967
    Abstract: The invention relates to a use of surface active hydrophobins for applications in pharmaceutical technology, in particular as excipients for galenic use. Provided is a method for either admixture of hydrophobins to galenic compositions or for treating the surface of pharmaceutical forms with a hydrophobin-containing solution to modify the pharmaceutical properties of the galenic form. In a preferred embodiment of the invention hydrophobins are used to improve the properties of a pharmaceutical composition, e.g. to act as a surfactant or to increase resistance to disintegration of the galenic forms to achieve a retarded drug release. The galenic form to be modified by the use of surface active proteins as excipients can be capsules, tablets, pills, microparticles, vesicles, and suppositories, although further galenic forms are envisioned.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: July 24, 2012
    Assignee: BASF SE
    Inventors: Andreas Buthe, Andreas Hafner, Franz Kaufmann, Esther Gabor, Guido Meurer, Jürgen Eck, Gordon Bradley
  • Publication number: 20120093788
    Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.
    Type: Application
    Filed: March 3, 2010
    Publication date: April 19, 2012
    Applicant: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn
  • Publication number: 20110268792
    Abstract: The invention relates to a use of surface active hydrophobins for applications in pharmaceutical technology, in particular as excipients for galenic use. Provided is a method for either admixture of hydrophobins to galenic compositions or for treating the surface of pharmaceutical forms with a hydrophobin-containing solution to modify the pharmaceutical properties of the galenic form. In a preferred embodiment of the invention hydrophobins are used to improve the properties of a pharmaceutical composition, e.g. to act as a surfactant or to increase resistance to disintegration of the galenic forms to achieve a retarded drug release. The galenic form to be modified by the use of surface active proteins as excipients can be capsules, tablets, pills, microparticles, vesicles, and suppositories, although further galenic forms are envisioned.
    Type: Application
    Filed: November 13, 2009
    Publication date: November 3, 2011
    Applicant: BASF SE
    Inventors: Andreas Buthe, Andreas Hafner, Franz Kaufmann, Esther Gabor, Guido Meurer, Jürgen Eck, Gordon Bradley
  • Patent number: 7749366
    Abstract: The present invention relates to a device for the isolation and/or purification of nucleic acid molecules suitable to bind and/or inactivate inhibitors of the activity of reagents or enzymes used for DNA manipulation and to separate a plurality of nucleic acid molecules with respect to their size. Moreover, the invention relates to a method for the isolation of a nucleic acid molecule comprising applying a sample to the device of the invention wherein said nucleic acid molecule preferably represents a fraction of the metagenome of a given habitat. Furthermore, the invention relates to a method for the generation of at least one gene library comprising nucleic acid molecules isolated by the method of the invention and to a nucleic acid molecule isolated by the method of the invention.
    Type: Grant
    Filed: August 20, 2003
    Date of Patent: July 6, 2010
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Achim Quaiser, Torsten Ochsenreiter, Alexander H. Treusch, Arnulf Kletzin, Christa Schleper, Patrick Lorenz, Jürgen Eck
  • Patent number: 7700311
    Abstract: The invention relates to novel polypeptides which have the biological activity of an NAD- or NADP-dependent alcohol dehydrogenase. The invention furthermore relates to nucleic acids encoding said polypeptides, to nonhuman hosts or host cells and to reaction systems which may be used for preparing desired products. The polypeptides of the invention are preferably used in the preparation, starting from aldehydes or ketones, of primary and enantiomerically pure secondary alcohols which may serve as intermediates for medicaments. Alternatively, the polypeptides of the invention may also be employed in the reverse reaction, i.e. the oxidation of alcohols with the formation of aldehydes or ketones.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: April 20, 2010
    Assignee: Degussa AG
    Inventors: Renate Schulze, Patrick Lorenz, Jürgen Eck, Oliver May, Harald Gröger, Harald Trauthwein
  • Publication number: 20100047863
    Abstract: The present invention provides a polynucleotide or a pair of polynucleotides encoding an enzyme having nitrile hydratase (NHase) [E.C. 4.2.1.84] activity. Furthermore, a vector and a host comprising the disclosed polynucleotide or pair of polynucleotides and methods for the production of the same are provided. Moreover, the invention relates to a pair of polypeptides or a fusion protein having NHase activity, an antibody specifically binding to the pair of polypeptides or fusion protein, a primer or probe, which specifically hybridizes under stringent conditions to the disclosed polynucleotide or either one of the pair of polynucleotides, a composition comprising the polynucleotide or pair of polynucleotides, the pair of polypeptides or fusion protein, the antibody and/or one or more primers or probes of the invention and a method for the production of amides comprising the enantioselective conversion of nitrites.
    Type: Application
    Filed: April 5, 2007
    Publication date: February 25, 2010
    Applicant: B.R.A.I.N. AG
    Inventors: Jürgen Eck, Klaus Liebeton, Lutz Fischer, Sabine Lutz-Wahl, Martina Hensel, Christian Ewert, Marcus Wälz
  • Patent number: 7635567
    Abstract: A method for the determination of the responsiveness of an individual to mistletoe lectin or to (an) mistletoe lectin single chain(s), wherein the expression of a membrane-bound receptor for mistletoe lectin is characteristic of a corresponding responsiveness.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: December 22, 2009
    Assignee: Viscum AG
    Inventors: Johannes Müthing, Jasna Peter-Katalinic, Martin Langer, Babette Möckel, Jürgen Eck
  • Patent number: RE47528
    Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: July 23, 2019
    Assignee: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG
    Inventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn